HighTower Advisors
EGRX

HighTower Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

HighTower Advisors’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,208
Closed -$235K – 3285
2022
Q4 		$235K Buy
+8,208
New +$235K ﹤0.01% 2627